124 related articles for article (PubMed ID: 35784625)
1.
Vasavada S; Panneerselvam K; Amin R; Varatharajalu K; Okhuysen PC; Oliva ICG; Wang J; Grivas P; Thomas AS; Wang Y
Ann Gastroenterol; 2022; 35(4):393-399. PubMed ID: 35784625
[TBL] [Abstract][Full Text] [Related]
2. Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis.
Abu-Sbeih H; Herrera LN; Tang T; Altan M; Chaftari AP; Okhuysen PC; Jenq RR; Wang Y
J Immunother Cancer; 2019 Sep; 7(1):242. PubMed ID: 31488205
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Immune Checkpoint Inhibitor-related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal Infections.
Ma W; Gong Z; Abu-Sbeih H; Peng Y; Peng F; Zou F; Charabaty A; Okhuysen PC; McQuade JL; Altan M; Zhang HC; Thomas AS; Wang Y
Am J Clin Oncol; 2021 Aug; 44(8):402-408. PubMed ID: 34107499
[TBL] [Abstract][Full Text] [Related]
4. Incidence of immune checkpoint inhibitor-mediated diarrhea and colitis (imDC) in patients with cancer and preexisting inflammatory bowel disease: a propensity score-matched retrospective study.
Sleiman J; Wei W; Shah R; Faisal MS; Philpott J; Funchain P
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34158318
[TBL] [Abstract][Full Text] [Related]
5. Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis.
Abu-Sbeih H; Ali FS; Naqash AR; Owen DH; Patel S; Otterson GA; Kendra K; Ricciuti B; Chiari R; De Giglio A; Sleiman J; Funchain P; Wills B; Zhang J; Naidoo J; Philpott J; Gao J; Subudhi SK; Wang Y
J Clin Oncol; 2019 Oct; 37(30):2738-2745. PubMed ID: 31163011
[TBL] [Abstract][Full Text] [Related]
6. Checkpoint Inhibitor Colitis With Superimposed Clostridioides difficile Infection.
Mohammad AW; Kusnik A; Mostafa MR; Tan J; Strapko A
Cureus; 2023 Apr; 15(4):e37006. PubMed ID: 37139037
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
Gordon D; Young LR; Reddy S; Bergman C; Young JD
J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
[TBL] [Abstract][Full Text] [Related]
8. Immune Checkpoint Inhibitor-Mediated Diarrhea and Colitis: A Clinical Review.
Gong Z; Wang Y
JCO Oncol Pract; 2020 Aug; 16(8):453-461. PubMed ID: 32584703
[TBL] [Abstract][Full Text] [Related]
9. Implementing an immunotherapy toxicity (IOTOX) GI service improves outcomes in patients with immune-mediated diarrhea and colitis.
Saji A; Chopra M; Jacob J; Altan M; Alhalabi O; Shah AY; Qiao W; Wang Y; Thomas A
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5841-5852. PubMed ID: 36585982
[TBL] [Abstract][Full Text] [Related]
10. Role of C-Reactive Protein in Predicting the Severity and Response of Immune-Mediated Diarrhea and Colitis in Patients with Cancer.
Liu C; Shatila M; Mathew A; Machado AP; Thomas A; Zhang HC; Thomas AS; Faleck D; Funchain P; Philpott J; Grivas P; Obeid M; Carbonnel F; Wang Y
J Cancer; 2023; 14(10):1913-1919. PubMed ID: 37476185
[No Abstract] [Full Text] [Related]
11. Mirroring UC care pathways in refractory immune checkpoint inhibitor (ICI)-mediated colitis: distinct features and common pathways.
Sleiman J; Brand RM; Pai R; Brand RE; Rhee J; Schwartz M; Davar D
Clin J Gastroenterol; 2023 Oct; 16(5):680-684. PubMed ID: 37452993
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease.
Tariq R; Disbrow MB; Dibaise JK; Orenstein R; Saha S; Solanky D; Loftus EV; Pardi DS; Khanna S
Inflamm Bowel Dis; 2020 Aug; 26(9):1415-1420. PubMed ID: 31821444
[TBL] [Abstract][Full Text] [Related]
13. A case of refractory immune checkpoint inhibitor-induced colitis with
Okura Y; Kobayashi K; Yamada Y; Furuya M; Kitano N; Oshina E; Matsuoka M; Nozaka T; Tashiro Y; Sato A; Yauchi M; Matsumoto T; Furumoto Y; Asano T; Azuma S
DEN Open; 2023 Apr; 3(1):e176. PubMed ID: 36262219
[TBL] [Abstract][Full Text] [Related]
14. Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients.
Miller R; Morillas JA; Brizendine KD; Fraser TG
J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896665
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.
Freedberg DE; Salmasian H; Friedman C; Abrams JA
Am J Gastroenterol; 2013 Nov; 108(11):1794-801. PubMed ID: 24060760
[TBL] [Abstract][Full Text] [Related]
16. Class-Specific Relationship Between Use of Immunosuppressants and Risk for Community-Acquired Clostridioides difficile Infection.
Varma S; Greendyke WG; Li J; Freedberg DE
Clin Infect Dis; 2022 Mar; 74(5):793-801. PubMed ID: 34156442
[TBL] [Abstract][Full Text] [Related]
17. Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis.
Zou F; Wang X; Glitza Oliva IC; McQuade JL; Wang J; Zhang HC; Thompson JA; Thomas AS; Wang Y
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33436487
[TBL] [Abstract][Full Text] [Related]
18. The evaluation of Clostridium difficile infection (CDI) in a community hospital.
Daniel A; Rapose A
J Infect Public Health; 2015; 8(2):155-60. PubMed ID: 25301221
[TBL] [Abstract][Full Text] [Related]
19. Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World Setting.
Bonanno L; Lorenzi M; Massa D; De Nuzzo M; Angerilli V; Zingone F; Barberio B; Russi A; Girardi F; Ferro A; Dal Maso A; Frega S; Pasello G; Dei Tos AP; Coppola M; Fassan M; Savarino EV; Guarneri V
Oncologist; 2024 Jan; 29(1):e118-e130. PubMed ID: 37603442
[TBL] [Abstract][Full Text] [Related]
20. Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea.
Kelly CP; Chen X; Williams D; Xu H; Cuddemi CA; Daugherty K; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR
Clin Infect Dis; 2020 Mar; 70(6):1083-1093. PubMed ID: 31211839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
